05/29/2024
7:11 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:12 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:28 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
4:20 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:46 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
5:14 PM | Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
04/01/2024
7:27 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:02 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
7:05 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:09 PM | Axsome Therapeutics (Subject)
JEFFS ROGER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:25 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:18 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:20 PM | Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:39 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:10 AM | Axsome Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:46 PM | Axsome Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:26 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/08/2024
6:10 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:11 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:39 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:30 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/12/2023
7:33 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
4:03 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
5:30 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:32 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
6:45 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
7:21 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
7:51 PM | Axsome Therapeutics (Filer)
| Form 424B5 | |
06/26/2023
4:01 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:35 PM | Axsome Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2023
4:22 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
5:21 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
5:22 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Obama’s Forever Term [exposed] (Ad) Over a decade ago, I tried to warn you...
Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America.  Start streaming it now at no cost here |
06/06/2023
5:22 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
